Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOVELASS: EVLA vs Polidocanol Foam for SSV Insufficiency
NCT05468450Completed
- Sponsor
- Société Française de Phlébologie
- Start
- Jul 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of 10XB101 (2 arms), sponsored by Société Française de Phlébologie. Primary endpoint: Absence of reflux in the treated SSV segment at 3 years. Started Jul 2015; status: completed.
02
Drugs
10XB101
Beyond the preview
Go deeper on NCT05468450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05468450.